Details for 2019211345
Up to date per 01.04.2026
Actions
Details for 2019211345
Granted/Registered
European Patent
13.05.2020 A
06.10.2021 B1
27.08.2013
US
201361870712 P
01.11.2013
US
201361898690 P
21.11.2013
US
201361907308 P
A61K 9/16 20060101AFI20210127BHEP
Owner
Gilead Pharmasset LLC333 Lakeside Drive Foster City, CA 94404US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
GORMAN, Ericc/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA California 94404US
MOGALIAN, Erikc/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA California 94404US
OLIYAI, Rezac/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA California 94404US
STEFANIDIS, Dimitriosc/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA California 94404US
WISER, Laurenc/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA California 94404US
ZIA, Vahidc/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA California 94404US
Information about Fees